These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3177335)

  • 1. Effect of calcitonin replacement therapy in idiopathic juvenile osteoporosis.
    Jackson EC; Strife CF; Tsang RC; Marder HK
    Am J Dis Child; 1988 Nov; 142(11):1237-9. PubMed ID: 3177335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineral metabolism and calcitriol therapy in idiopathic juvenile osteoporosis.
    Saggese G; Bertelloni S; Baroncelli GI; Perri G; Calderazzi A
    Am J Dis Child; 1991 Apr; 145(4):457-62. PubMed ID: 2012031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined treatment with calcitonin and 1,25-dihydroxyvitamin D3 for osteoporosis in women.
    Eriksson SA; Lindgren JU
    Calcif Tissue Int; 1993 Jul; 53(1):26-8. PubMed ID: 8348381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sequential calcitriol-calcitonin in the therapy of osteoporosis].
    Passeri M; Palummeri E; Barbagallo M; Butturini L; Pedrazzoni M; Davoli L; Pioli G; Benassi L; Girasole G; Ciotti G
    Minerva Endocrinol; 1989; 14(1):57-62. PubMed ID: 2659953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of post-menopausal osteoporosis with phosphate and intermittent calcitonin.
    Kuntz D; Marie P; Berhel M; Caulin F
    Int J Clin Pharmacol Res; 1986; 6(2):157-62. PubMed ID: 3522444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
    J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salmon calcitonin and calcium in the treatment of male osteoporosis: the effect on bone mineral density.
    Erlacher L; Kettenbach J; Kiener H; Graninger W; Kainberger F; Pietschmann P
    Wien Klin Wochenschr; 1997 Apr; 109(8):270-4. PubMed ID: 9163888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New approaches to the problems of osteoporosis.
    Nordin BE; Need AG; Morris HA; Horowitz M
    Clin Orthop Relat Res; 1985 Nov; (200):181-97. PubMed ID: 3905110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of osteoporosis with calcitonin, with and without growth hormone.
    Aloia JF; Vaswani A; Kapoor A; Yeh JK; Cohn SH
    Metabolism; 1985 Feb; 34(2):124-9. PubMed ID: 3969014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of monotherapy and combined therapy with calcitonin and minodronic acid hydrate, a bisphosphonate, for early treatment in patients with new vertebral fractures: An open-label, randomized, parallel-group study.
    Tanaka S; Yoshida A; Kono S; Ito M
    J Orthop Sci; 2017 May; 22(3):536-541. PubMed ID: 28108224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms underlying the effects of phosphate and calcitonin on bone histology in postmenopausal osteoporosis.
    Marie PJ; Caulin F
    Bone; 1986; 7(1):17-22. PubMed ID: 3964494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitonin and calcium combined therapy in osteoporosis: effects on vertebra trabecular bone density.
    Ozoran K; Paker N; Başgöze O; Hasçelik Z; Erzen C; Narman S; Ozker R
    J Int Med Res; 1989; 17(4):395-400. PubMed ID: 2792558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcitriol deficiency in idiopathic juvenile osteoporosis.
    Marder HK; Tsang RC; Hug G; Crawford AC
    Am J Dis Child; 1982 Oct; 136(10):914-7. PubMed ID: 6896958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of osteoporosis and Paget's disease. An appraisal of the risks and benefits of drug treatment.
    Gennari C; Nuti R; Agnusdei D; Camporeale A; Martini G
    Drug Saf; 1994 Sep; 11(3):179-95. PubMed ID: 7811400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy for osteoporosis.
    Aloia JF; Zanzi I; Vaswani A; Ellis K; Cohn SH
    Metabolism; 1977 Jul; 26(7):787-92. PubMed ID: 559229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of oestrogens.
    Stevenson JC; Abeyasekera G; Hillyard CJ; Phang KG; MacIntyre I; Campbell S; Townsend PT; Young O; Whitehead MI
    Lancet; 1981 Mar; 1(8222):693-5. PubMed ID: 6110915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a one-year administration of phosphate and intermittent calcitonin on bone-forming and bone-resorbing cells in involutional osteoporosis: a histomorphometric study.
    Alexandre C; Chappard D; Caulin F; Bertrand A; Palle S; Riffat G
    Calcif Tissue Int; 1988 Jun; 42(6):345-50. PubMed ID: 3135102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical management of osteoporosis.
    Mulloy AL; Weinstein RS
    J Med Assoc Ga; 1994 Apr; 83(4):227-30. PubMed ID: 8006552
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of calcitriol or calcium on bone mineral density, bone turnover, and fractures in men with primary osteoporosis: a two-year randomized, double blind, double placebo study.
    Ebeling PR; Wark JD; Yeung S; Poon C; Salehi N; Nicholson GC; Kotowicz MA
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4098-103. PubMed ID: 11549632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment with calcitonin in osteoporosis.
    Gennari C; Agnusdei D; Camporeale A
    Horm Metab Res; 1993 Sep; 25(9):484-5. PubMed ID: 8225202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.